Abstract
The study of the interaction between lipid membranes and amyloidogenic peptides is a turning point for understanding the processes involving the cytotoxicity of peptides involved in neurodegenerative diseases. In this work, we perform an experimental study of model membrane–lysozyme interaction to understand how the formation of amyloid fibrils can be affected by the presence of polar and zwitterionic phospholipid molecules (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine [POPC] and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol [POPG]). The study was conducted above and below the critical micellar concentration (CMC) using dynamic light scattering (DLS), atomic force microscopy (AFM), UV–Vis spectrophotometry, and the quartz crystal microbalance (QCM). Our results show that the presence of phospholipids appears to be a factor favoring the formation of amyloid aggregates. Spectrophotometric and DLS data revealed that the quantity of
Introduction
The misfolding and aggregation of otherwise functional proteins are known to be correlated with several neurodegenerative disorders, like Alzheimer’s and Parkinson’s diseases, as well as systemic amyloidoses [1]. Fundamental research projects focused on the fact that the protein fibrils found in association with these pathologies share common properties, such as a core rich in
Although the structural similarity between the mature amyloid aggregates [5–7] could suggest the existence of some generic mechanism of toxicity, it was suggested, in the last decades, that the oligomeric species, precursors of amyloid fibrils, were the most cytotoxic aggregates [8–12]. The existence of amyloid plaques and tangles in the brain was considered a common finding in Alzheimer’s pathology; however, results from the “Nun study” indicated that neurofibrillary tangles located in regions of the brain outside the neocortex and hippocampus may have less of an effect than plaques located within those areas [13], suggesting the possibility of compensatory biological mechanisms with respect to fibrils neurotoxicity, and/or other neurotoxic patterns [14].
The investigation of the interaction between amyloidogenic peptides and cell membranes is key to understanding the processes involved in their cytotoxicity. In the last decades, researchers have started to compare the cytotoxic processes induced by the same molecule in different states of aggregation (native, small oligomers, and large fibrils), without finding so far any general behavior. In some cases, the formation of large aggregates has been proposed as a self-defense process to hinder the interaction between fibrils and cell membranes and, in turn, prevent cellular damage. On the contrary, pronounced cytotoxicity was found when the same molecular species were forming small oligomers, i.e., at the onset of aggregation. For example, in the case of the human islet amyloid polypeptide (hIAPP), a peptide involved in type 2 Diabetes Mellitus, it was shown that small hIAPP oligomers promoted lipid depletion from cell membrane mimics while amyloidogenic aggregation inhibited the process of membrane permeation [15]. In this framework, the relationship between the protein aggregation pathway leading to the formation of amyloid fibrils and the presence of other biomolecules, such as lipids, that the proteins may encounter in body fluids has been investigated but is not yet fully understood. Indeed, the presence of lipid molecules in and around amyloid fibrils was confirmed by different studies [16–18] and excluded by others [19]. Furthermore, it is not yet clear how the presence of lipids in solution can modify not just fibrils structure but even their nucleation and growth. Another debated topic is the influence of the aggregation state of the lipid molecules on the formation of fibrils. Lindberg et al. [20] showed that the presence of lipid vesicles composed of zwitterionic molecules accelerates the fibril growth rate for A
In the current work, we combined surface- and solution-sensitive techniques to investigate process of formation and growth of fibrils for a well-known peptide such as lysozyme (LYS) in the presence of polar and zwitterionic phospholipid molecules at concentrations below and above their critical micellar concentration (CMC), i.e., for solution containing only free lipid molecules (below 1 CMC), and a mixture of free molecules and lamellar aggregates (at and above 1 CMC). Our results show that, already at a concentration of 1 CMC, the presence of charged or zwitterionic lipid species free in solution augments the fibrils growth rate, with no clear differences for higher concentration values and no evident differences in mature fibrils structure. Moreover, we have monitored the interaction of native LYS, LYS fibrils, and LYS–lipid aggregates with a model bilayer composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), a zwitterionic phospholipid largely abundant in mammalian cell membranes. From these experiments, a clear trend shows that the affinity of aggregates for the POPC membrane is enhanced for LYS–lipid aggregates, while it is limited for LYS monomers and very small oligomers.
Materials and methods
Materials
Hen egg white lysozyme (LYS), glycine and Congo Red (CR) were purchased from Merck (Darmstadt, Germany). Phospholipids powders, POPC, and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) were purchased from Avanti Polar Lipids (Alabaster, USA).
CR is water soluble, but its solubility is better in organic solvents such as ethanol. We prepared an acqueous ethanol solution (80% w/w) saturated with NaCl. This solution was then saturated with CR powder and filtered with 0.2
In order to measure the effect of lipids on LYS aggregation from the early onset of the process, lipid solutions were added to LYS shortly before the start of each kinetic of aggregation. For these samples, LYS and lipid were prepared at the proper concentration to maintain the final concentration of 3 mg/mL of LYS for all samples.
UV-Visible (UV-Vis) spectrophotometry
UV-Vis spectrophotometry experiments performed in the presence of CR can be used to monitor protein aggregation into amyloid structures. CR has a high affinity for
DLS
DLS is a technique commonly used to measure the size distribution of colloidal particles in solution. In the present case, DLS was used to track the aggregation of LYS over time, both in the absence and presence of lipid molecules. Experiments were performed on a Malvern Zetasizer Pro instrument (Malvern Panalytical, UK) configured in back-scattering geometry (scattering angle,
where
Quartz crystal microbalance (QCM)
QCM is a technique widely used to monitor adsorption processes at solid interfaces [32]. Briefly, this technique measures the frequency of vibration of a quartz crystal subject to an alternating potential. Changes in this frequency (
where
Atomic force microscopy (AFM)
AFM measurements were performed on an AIST-NT scanning probe microscope (Horiba Scientific, Kyoto, Japan). Images were acquired in non-contact mode with a pyramidal silicon tip of radius of 8 nm. Samples were prepared from the batches that reached the end point of fibrillation and diluting them from the original concentration by a factor 1:1,000. The dilution factor was optimized empirically to avoid the deposition of more than one layer of peptides onto the mica surface. Briefly,
Results and discussion
LYS amyloid aggregation was first monitored by UV–Vis spectrophotometry with CR. LYS is a model protein whose amyloidogenesis in the presence of osmolites had already been studied by the same approach [24,25]. The sigmoidal behavior of the growth of fibrils, which results from the red shift of CR absorption peak, is related to a kinetic process that can be compared to the one revealed by adding Thioflavin T to the protein solution and measuring fluorescence emission [38]. The sigmoidal growth of the signal can be quantitatively evaluated, and in particular, the time needed to reach the first half of the process can be obtained. The halftime can be considered as a measure of mutational effects on nucleation. As previously suggested, primary nucleation is not the only microscopic process during the lag time of aggregation [39]. Fibril-catalyzed secondary nucleation has been observed for the aggregation of A

(a) UV-Vis spectroscopy results of lysozyme in solution in the presence of CR at the beginning (violet) and the end (green) of its aggregation pattern in the presence of POPG at 1 CMC, not extruded. The arrow indicates how the absorbance peak of CR shifts at higher wavelength when bound to

UV/Vis spectroscopy results on the effect of POPC and POPG, both at a concentration equal to 1 CMC, on lysozyme aggregation pattern. Histograms show the halftime obtained from the theoretical fitting of each aggregation pattern.
The aggregation of LYS in solution and in the presence and absence of different phospholipid molecules, before and after extrusion, was also evaluated by DLS. These experiments were conducted on arrested states of aggregation kinetics, i.e., by taking 1 mL aliquots from the stock solution at regular time intervals and measuring them after their temperature was lowered to

Left: intensity auto-correlation functions (

AFM images for (a) LYS, (b) LYS + POPG at 25% CMC, not-extruded, (c) LYS + POPG at 50% CMC, not-extruded, (d) LYS + POPG 1 CMC, not-extruded, and (e) LYS + POPG 1 CMC, extruded . Scale bar is 1

Left: Intensity auto-correlation functions (symbols) for lysozyme in the presence of non-extruded POPC molecules at a concentration equal to 1 CMC. Data were acquired at 30 minutes intervals from the beginning of the aggregation process. The arrow indicates the major changes in the correlation curves taking place with time. Red lines are the model curves obtained from the analyzis. The increase in the experimental data visible at short times for some curves is an instrumental artifact. Right: Intensity-weighted distributions of the hydrodynamic radius,
Kinetics of aggregation were monitored for a total of 2 h in the case of POPC and 1 h in the case of POPG, both in extruded and non-extruded forms. Intensity auto-correlation functions and the size distributions resulting from their analyzis are shown in Figures 5 and S1 for POPC and in Figures S2 and S3 for POPG. In all samples, the signal previously ascribed to LYS monomers and small oligomers was present. However, the contribution of this population was reduced to less than 50% of the total scattered intensity in the first 30 min for non-extruded POPC and almost disappeared in the presence of non-extruded POPG. In turn, the growth of a population of aggregates with
A very similar trend was observed in the presence of POPC and POPG LUVs (Figures S1 and S3 in the Supplementary material). This was not unexpected as, at such concentration, the majority of lipid molecules are present in solution as monomers. The absence of noticeable differences in the DLS data measured with and without extruding the lipid solutions confirms the UV–Vis observations previously described. We underline that in all cases, the main changes were observed in the amount of LYS molecules contributing to different particle populations, while the size of these populations did not change appreciably during the aggregation processes.
In order to determine the morphology of the aggregates present in solution at the end of the aggregation process, we used AFM. AFM images for a set of the investigated samples are shown in Figure 4. The presence of amyloid fibrils, with typical length on the order of microns, is evident for all the samples. Their height, as well as of their width, resulted to be of a few nanometers, as in previous investigation on similar samples [24,45]. As the determination of the lateral size of particles with AFM is limited by tip-induced effects, we limited the quantitative analysis to the height determination. The latter was determined by sampling at least 50 aggregates per image, considering three images for each sample, and using the Gwyddions software. Their mean height values and the associated statistical error are shown in Figure 6 for the LYS and LYS + POPG samples, and in Figures S4 and S5 for LYS + POPC samples.

Mean value for fibrils height determined from AFM images.
The presence of amyloid fibrils was revealed in all the samples, and no significant height differences were found between LYS + POPG and LYS + POPC samples.
UV–Vis spectroscopy and DLS experiments clearly indicated that the rate of aggregation is influenced by the presence of phospholipids in solution, even when their concentration is not sufficient to promote the formation of self-assembled structure, i.e., when it is lower than 1 CMC. LYS amyloid fibrils interaction with model membranes had been investigated, suggesting that fibrils induce reduction of bilayer hydration and increase of lipid packing in the interfacial region of model membranes [46]. However, at our knowledge no investigation has been performed on the influence of model membranes on LYS amyloid aggregation. On the other side, the influence of model membranes on peptides involved in severe diseases, like amyloid
In order to investigate the interaction of LYS, prepared at different stages of fibrillation alone and in the presence of lipid cosolutes, we performed QCM experiments using a POPC SLB as target model membrane. The SLB was deposited using the vesicle fusion method onto a silica-coated QCM sensor as described in the Materials and Methods section. The quality of the SLB was evaluated by measuring the frequency shift obtained after removal of any unfused vesicle and unbound lipid material. Afterwards, aliquots taken from the solution undergoing aggregation (containing either LYS or LYS + POPC) were injected in the sample cell using a peristaltic pump and left to incubate in stagnant flow condition. The interaction was monitored for 2 h. Finally, the process was stopped by rinsing the sample chamber with pure buffer to remove any unbound material and to evaluate the stability of the adsorbed layer.
The absolute frequency measured for the POPC SLB was taken as reference for the calculation of the frequency shifts (expected

Changes of the 10 MHz frequency upon interaction between native lysozyme and a pre-formed POPC SLB.
The presence of LYS aggregates in the solution promoted a faster interaction, as well as a larger adsorbed amount. Indeed, upon injection of the LYS aliquot taken 30 minutes after the onset of aggregation, the adsorption kinetics resulted faster (

Frequency shifts (
The QCM results, supported by the evidence provided by UV–Vis and DLS indicating the increased presence of aggregates in the LYS + lipids samples, suggest that aggregates are more prone to interact with a zwitterionic model membrane causing accumulation of material in its proximity. Upon interaction, aggregates are bound to the membrane as they are not removed during the rinsing steps applied. However, with the techniques used, it is not possible to determine their location and the structure and morphology of the final lipid–LYS film. As adsorption resulted to be enhanced for aggregates and as the solution flows on the top of the QCM sensor, a partial contribution of sedimentation cannot be excluded a priori. This hypothesis can be confuted on the basis of the DLS and AFM data, which indicate that the size of the aggregates was similar for all investigated samples. Sedimentation depends on the size of the particles, and therefore, the different rates of adsorption observed in QCM experiments cannot be simply originated by this phenomenon. Moreover, sedimentation for the native LYS solution (containing mostly monomers and small oligomers) is negligible in the 2-h time-window probed during QCM experiments. Finally, in none of the transparent vials containing the solutions having reached the final stage of aggregation was noted any sediment.
Conclusion
In conclusion, the current data showed that the presence of phospholipids appeared to be a factor favoring the formation of amyloid aggregates. Indeed, UV–Vis spectrophotometry data revealed that the amount of
Acknowledgments
All authors acknowledge the Department of Life and Environmental Science (DISVA) in Marche Polytechnic University (UNIVPM) for providing access to the DLS instrument acquired within the project for Excellence Departments funded by MIUR (art. 1, comma 314-338, D Lgs 232, 2016).
-
Funding information: MGO thanks for the economic support provided by the European Union-Next Generation EU, Project Code: ECS00000041, Project Title: Innovation, digitalization and sustainability for the diffused economy in Central Italy-VITALITY. YG acknowledges the support by the “Fondo di Solidarietá Scientifica” awarded by the DISVA department (UNIVPM) for the purchase and commissioning of the QCM apparatus.
-
Conflict of interest: Authors state no conflict of interest.
-
Data availability statement: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
[1] Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–66. 10.1146/annurev.biochem.75.101304.123901Search in Google Scholar PubMed
[2] Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-beta spine of amyloid fibrils. Nature. 2005;435:773–8. 10.1038/nature03680Search in Google Scholar PubMed PubMed Central
[3] Langkilde AE, Vestergaard B. Methods for structural characterization of prefibrillar intermediates and amyloid fibrils. FEBS Letters. 2009;583(16):2600–9. 10.1016/j.febslet.2009.05.040. Search in Google Scholar PubMed
[4] Goldschmidt L, Teng PK, Riek R, Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Nat Acad Sci. 2010;107(8):3487–92. 10.1073/pnas.0915166107Search in Google Scholar PubMed PubMed Central
[5] Cao Y, Mezzenga R. Food protein amyloid fibrils: Origin, structure, formation, characterization, applications and health implications. Adv Colloid Interface Sci. 2019;269:334–56. https://www.sciencedirect.com/science/article/pii/S0001868619301058. 10.1016/j.cis.2019.05.002Search in Google Scholar PubMed
[6] Martorana V, Raccosta S, Giacomazza D, Ditta LA, Noto R, Biagio PLS, et al. Amyloid jams: mechanical and dynamical properties of an amyloid fibrillar network. Biophys Chemistry. 2019;253:106231. https://www.sciencedirect.com/science/article/pii/S030146221930290X. 10.1016/j.bpc.2019.106231Search in Google Scholar PubMed
[7] Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE. A new era for understanding amyloid structures and disease. Nature Rev Mol Cell Biol. 2018;19:755–73. 10.1038/s41580-018-0060-8Search in Google Scholar PubMed
[8] Glabe CG, Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology. 2006;66 (1 suppl 1):S74–8. https://n.neurology.org/content/66/1_suppl_1/S74. 10.1212/01.wnl.0000192103.24796.42Search in Google Scholar PubMed
[9] Lorenzen N, Nielsen SB, Yoshimura Y, Vad BS, Andersen CB, Betzer C, et al. How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro. J Biol Chem. 2014;289(31):21299–310. 10.1074/jbc.M114.554667Search in Google Scholar PubMed PubMed Central
[10] Cohen SIA, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, et al. Proliferation of amyloid-β 42 aggregates occurs through a secondary nucleation mechanism. Proc Nat Acad Sci. 2013;110(24):9758–63. 10.1073/pnas.1218402110. Search in Google Scholar PubMed PubMed Central
[11] Oropesa-Nunnnez R, Seghezza S, Dante S, Diaspro A, Cascella R, Cecchi C, et al. Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy. Oncotarget. 2016;7(29):44991–5004. http://www.oncotarget.com/fulltext/10449. 10.18632/oncotarget.10449Search in Google Scholar PubMed PubMed Central
[12] Malmo C, Vilasi S, Iannuzzi C, Tacchi S, Cametti C, Irace G, et al. Tetracycline inhibits W7FW14F apomyoglobin fibril extension and keeps the amyloid protein in a pre-fibrillar, highly cytotoxic state. FASEB J. 2006;20:346–7. 10.1096/fj.05-4652fjeSearch in Google Scholar PubMed
[13] Iacono D, Markesbery WR, Gross M, Pletnikova O, Rudow G, Zandi P, et al. The Nun study. Neurology. 2009;73(9):665–73. https://n.neurology.org/content/73/9/665. 10.1212/WNL.0b013e3181b01077Search in Google Scholar PubMed PubMed Central
[14] Broersen K, Rousseau F, Schymkowitz J. The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer’s disease: oligomer size or conformation? Alzheimers Res Ther. 2010;2(4):12. http://www.ncbi.nlm.nih.gov/pubmed/20642866. 10.1186/alzrt36Search in Google Scholar PubMed PubMed Central
[15] Martel A, Antony L, Gerelli Y, Porcar L, Fluitt A, Hoffmann K, et al. Membrane permeation versus amyloidogenicity: a multitechnique study of Islet amyloid polypeptide interaction with model membranes. J Amer Chem Soc. 2017;139(1):137–48. 10.1021/jacs.6b06985Search in Google Scholar PubMed
[16] Bacon H, Toppozini L, Rheinstädter M. The interaction between amyloid-β peptides and anionic lipid membranes containing cholesterol and melatonin. PLoS One. 2014 June;9:e99124.10.1371/journal.pone.0099124Search in Google Scholar PubMed PubMed Central
[17] Hane F, Drolle E, Gaikwad R, Faught E, Leonenko Z. Amyloid-beta aggregation on model lipid membranes: an atomic force microscopy study. J Alzheimers Dis. 2011 June;26:485–94. 10.3233/JAD-2011-102112Search in Google Scholar PubMed
[18] Sanderson JM. The association of lipids with amyloid fibrils. J Biol Chem. 2022 Aug;298(8):102108. 10.1016/j.jbc.2022.102108Search in Google Scholar PubMed PubMed Central
[19] Dubackic M, Linse S, Sparr E, Olsson U. Comparing α-synuclein fibrils formed in the absence and presence of a model lipid membrane: a small and wide-angle X-ray scattering study. Front Soft. Matter. 2022;1:741996. https://www.frontiersin.org/articles/10.3389/frsfm.2021.741996. 10.3389/frsfm.2021.741996Search in Google Scholar
[20] Lindberg DJ, Wenger A, Sundin E, Wesén E, Westerlund F, Esbjörner EK. Binding of Thioflavin-T to amyloid fibrils leads to fluorescence self-quenching and fibril compaction. Biochemistry. 2017;56(16):2170–4. 10.1021/acs.biochem.7b00035Search in Google Scholar PubMed
[21] Scollo F, Tempra C, Lolicato F, Sciacca MFM, Raudino A, Milardi D, et al. Phospholipids critical micellar concentrations trigger different mechanisms of intrinsically disordered proteins interaction with model membranes. J Phys Chem Lett. 2018 Aug;9(17):5125–9. 10.1021/acs.jpclett.8b02241Search in Google Scholar PubMed
[22] Sciacca MF, Lolicato F, Tempra C, Scollo F, Sahoo BR, Watson MD, et al. Lipid-chaperone hypothesis: a common molecular mechanism of membrane disruption by intrinsically disordered proteins. ACS Chem Neurosci. 2020 Dec;11(24):4336–50. 10.1021/acschemneuro.0c00588Search in Google Scholar PubMed PubMed Central
[23] Poniková S, Antošová A, Demjén E, Sedláková D, Marek J, Varhač R, et al. Lysozyme stability and amyloid fibrillization dependence on Hofmeister anions in acidic pH. J Biol Inorganic Chem. 2015;20(6):921–33. 10.1007/s00775-015-1276-0Search in Google Scholar PubMed
[24] Mastrella L, Moretti P, Pieraccini S, Magi S, Piccirillo S, Ortore MG. Taurine stabilizing effect on lysozyme. Life. 2022 Jan;12(1):133. 10.3390/life12010133. Search in Google Scholar PubMed PubMed Central
[25] Mari E, Ricci C, Pieraccini S, Spinozzi F, Mariani P, Ortore MG. Trehalose effect on the aggregation of model proteins into amyloid fibrils. Life. 2020;10(5):60. https://www.mdpi.com/2075-1729/10/5/60. 10.3390/life10050060Search in Google Scholar PubMed PubMed Central
[26] Klunk WE, Jacob RF, Mason RP. Quantifying amyloid by congo red spectra shift assay. Methods Enzymol. 1999;309(1974):6879. 10.1016/S0076-6879(99)09021-7Search in Google Scholar PubMed
[27] Khurana R, Uversky VN, Nielsen L, Fink AL. Is congo red an amyloid-specific dye? J Biol Chem. 2001;276(25):22715–21. 10.1074/jbc.M011499200Search in Google Scholar PubMed
[28] Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods. 2004;34(1):151–60. 10.1016/j.ymeth.2004.03.012Search in Google Scholar PubMed
[29] Howie AJ, Brewer DB. Optical properties of amyloid stained by Congo red: History and mechanisms. Micron. 2009;40(3):285–301. https://www.sciencedirect.com/science/article/pii/S0968432808002187. 10.1016/j.micron.2008.10.002Search in Google Scholar PubMed
[30] Espargar A, Llabró S, Saupe SJ, Curutchet C, Luque FJ, Sabaté R. On the binding of congo red to amyloid fibrils. Angewandte Chemie Int Edition. 2020;59(21):8104–7. https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.201916630. 10.1002/anie.201916630Search in Google Scholar PubMed
[31] Marino IG. RILT; https://la.mathworks.com/matlabcentral/fileexchange/6523-rilt. Search in Google Scholar
[32] Easley AD, Ma T, Eneh CI, Yun J, Thakur RM, Lutkenhaus JL. A practical guide to quartz crystal microbalance with dissipation monitoring of thin polymer films. J Polymer Sci. 2022;60(7):1090–107. 10.1002/pol.20210324Search in Google Scholar
[33] Sauerbrey G. Verwendung von Schwingquarzen zur Wägung dü nner Schichten und zur Mikrowägung. Z Phys. 1959;155(2):206–22. 10.1007/BF01337937Search in Google Scholar
[34] Höök F. Development of a novel QCM technique for protein adsorption studies. Göteborg, Sweden: Chalmers University of Technology; 1997. Search in Google Scholar
[35] Kalb E, Frey S, Tamm LK. Formation of supported planar bilayers by fusion of vesicles to supported phospholipid monolayers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1992;1103(2):307–16. 10.1016/0005-2736(92)90101-QSearch in Google Scholar
[36] Cremer PS, Boxer SG. Formation and spreading of lipid bilayers on planar glass supports. J Phys Chem B. 1999;103(13):2554–59. 10.1021/jp983996xSearch in Google Scholar
[37] Montis C, Gerelli Y, Fragneto G, Nylander T, Baglioni P, Berti D. Nucleolipid bilayers: a quartz crystal microbalance and neutron reflectometry study. Colloids Surfaces B Biointerfaces. 2016;137:203–13. 10.1016/j.colsurfb.2015.07.039Search in Google Scholar PubMed
[38] Holm NK, Jespersen SK, Thomassen LV, Wolff TY, Sehgal P, Thomsen LA, et al. Aggregation and fibrillation of bovine serum albumin. Biochimica et Biophysica Acta - Proteins and Proteomics. 2007;1774(9):1128–38. 10.1016/j.bbapap.2007.06.008Search in Google Scholar PubMed
[39] Arosio P, Knowles TPJ, Linse S. On the lag phase in amyloid fibril formation. Phys Chem Chem Phys. 2015;17:7606–18. 10.1039/C4CP05563B. Search in Google Scholar PubMed PubMed Central
[40] Meisl G, Yang X, Hellstrand E, Frohm B, Kirkegaard JB, Cohen SIA, et al. Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ 40 and Aβ 42 peptides. Proc Nat Acad Sci. 2014;111(26):9384–9. http://www.pnas.org/lookup/doi/10.1073/pnas.1401564111. 10.1073/pnas.1401564111Search in Google Scholar PubMed PubMed Central
[41] Buell AK, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles TPJ, et al. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation. Proc Nat Acad Sci. 2014;111(21):7671–6. https://www.pnas.org/doi/abs/10.1073/pnas.1315346111. 10.1073/pnas.1315346111Search in Google Scholar PubMed PubMed Central
[42] Hsu F, Park G, Guo Z. Key residues for the formation of Aβ 42 amyloid fibrils. ACS Omega. 2018;3(7):8401–7. PMID: 30087945. https://doi.org/10.1021/acsomega.8b00887. Search in Google Scholar PubMed PubMed Central
[43] Pande AH, Kar S, Tripathy RK. Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipids. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2010;1798(3):442–52. https://www.sciencedirect.com/science/article/pii/S0005273610000039. 10.1016/j.bbamem.2009.12.028Search in Google Scholar PubMed
[44] García de la Torre J, Huertas ML, Carrasco B. Calculation of hydrodynamic properties of globular proteins from their atomic-level structure. Biophys J. 2000;78(2):719–30. 10.1016/S0006-3495(00)76630-6Search in Google Scholar PubMed PubMed Central
[45] Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 1997;385:787–93. https://www.nature.com/articles/385787a0#article-info. 10.1038/385787a0Search in Google Scholar PubMed
[46] Kastorna A, Trusova V, Gorbenko G, Kinnunen P. Membrane effects of lysozyme amyloid fibrils. Chem Phys Lipids. 2012;165(3):331–7. https://www.sciencedirect.com/science/article/pii/S0009308412000199. 10.1016/j.chemphyslip.2012.02.002Search in Google Scholar PubMed
[47] Rasmussen H, Otzen D, Pedersen J. Induction, inhibition, and incorporation: Different roles for anionic and zwitterionic lysolipids in the fibrillation of the functional amyloid FapC. J Biol Chem. 2022 Feb;298(2):101569.10.1016/j.jbc.2022.101569Search in Google Scholar PubMed PubMed Central
© 2023 the author(s), published by De Gruyter
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Research Articles
- Dipalmitoyl-phosphatidylserine-filled cationic maltodextrin nanoparticles exhibit enhanced efficacy for cell entry and intracellular protein delivery in phagocytic THP-1 cells
- Potential PDE4B inhibitors as promising candidates against SARS‐CoV‐2 infection
- Mitigation of the hyperglycemic effect of streptozotocin-induced diabetes albino rats using biosynthesized copper oxide nanoparticles
- Review Article
- Proteins turn “Proteans” – The over 40-year delayed paradigm shift in structural biology: From “native proteins in uniquely defined configurations” to “intrinsically disordered proteins”
- Communication
- 7Be and 22Na radionuclides for a new therapy for cancer
- Special Issue on XXVI SIBPA congress 2022
- Head or tail? A molecular dynamics approach to the complex structure of TNF-associated factor TRAF2
- Setting up multicolour TIRF microscopy down to the single molecule level
- Effects of model membranes on lysozyme amyloid aggregation
- Modeling of olfactory transduction in AWCON neuron via coupled electrical-calcium dynamics
- A commentary on the inhibition of human TPC2 channel by the natural flavonoid naringenin: Methods, experiments, and ideas
Articles in the same Issue
- Research Articles
- Dipalmitoyl-phosphatidylserine-filled cationic maltodextrin nanoparticles exhibit enhanced efficacy for cell entry and intracellular protein delivery in phagocytic THP-1 cells
- Potential PDE4B inhibitors as promising candidates against SARS‐CoV‐2 infection
- Mitigation of the hyperglycemic effect of streptozotocin-induced diabetes albino rats using biosynthesized copper oxide nanoparticles
- Review Article
- Proteins turn “Proteans” – The over 40-year delayed paradigm shift in structural biology: From “native proteins in uniquely defined configurations” to “intrinsically disordered proteins”
- Communication
- 7Be and 22Na radionuclides for a new therapy for cancer
- Special Issue on XXVI SIBPA congress 2022
- Head or tail? A molecular dynamics approach to the complex structure of TNF-associated factor TRAF2
- Setting up multicolour TIRF microscopy down to the single molecule level
- Effects of model membranes on lysozyme amyloid aggregation
- Modeling of olfactory transduction in AWCON neuron via coupled electrical-calcium dynamics
- A commentary on the inhibition of human TPC2 channel by the natural flavonoid naringenin: Methods, experiments, and ideas